Elicio Therapeutics, Inc.
ELTXCIK 0001601485 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K/A filed Apr 29, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0018
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at Elicio Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Venkatesan Jay | OfficerDirector | 10 |
| Chudnovsky Yekaterina | Director10% Owner | 9 |
| Demuth Peter | Officer | 6 |
| Gkcc, LLC | 10% Owner | 6 |
| Nissenson Allen | Director | 5 |
Showing 1-5 of 18
Page 1 of 4Next
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at Elicio Therapeutics, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Venkatesan Jay | 3 | 0% | -19.3% | -19.8% | -17.9% | -20.3% |
All filings
61 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|